.Since the problem is actually entirely an OFS, the company is going to certainly not obtain any proceeds and all the funds will certainly most likely to the offering shareholders (Photo: Shutterstock) 2 minutes went through Final Updated: Oct 07 2024|5:52 PM IST.Integrated diagnostic chain Suraksha Diagnostic Ltd has acquired Sebi's go on to increase funds via a going public (IPO), an update with the marketplaces regulator revealed on Monday.The Kolkata-headquartered provider's planned IPO consists of an Offer-for-Sale (OFS) of up to 1.92 crore equity portions by promoters and real estate investor shareholders, without any fresh issue part, depending on to the Draft Wild-goose Chase Prospectus (DRHP). Go here to connect with our team on WhatsApp.Under the OFS, marketers-- Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma and also financiers-- OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal as well as Santosh Kumar Kejriwal will certainly unload portions..The company, which had actually filed preliminary IPO papers in July, got the regulator's observation on September 30, the upgrade showed.In Sebi's argot, obtaining its observations implies the regulatory authority's proceed to float the general public issue.According to the draft papers, the firm will certainly not obtain any kind of profits and all the funds will certainly visit the marketing investors as the issue is completely an OFS.Explaining the factor for going public, the business, in its draft papers, stated that the list is actually targeted at achieving the perk of noting equity shares on the stock market and carrying out OFS for the offering shareholders.Given that the concern is fully an OFS, the business will not get any sort of proceeds and all the funds are going to head to the offering shareholders.Suraksha Diagnostic uses a one-stop incorporated remedy for pathology and also radiology screening and also medical assessment services to its own customers by means of its own significant working network, including a flagship main recommendation laboratory, 8 gps laboratories and also 194 consumer touchpoints which include 48 diagnostic facilities, and 146 sample collection facilities (predominantly franchised), all over West Bengal, Bihar, Assam as well as Meghalaya as of March 31, 2024.Throughout fiscal 2024, it performed regarding 5.98 million tests providing around 1.14 thousand patients.ICICI Securities Ltd, Nuvama Wealth Control Ltd and also SBI Resources Markets Ltd are the book-running lead supervisors to the concern. The equity reveals are actually suggested to be listed on BSE and also NSE.( Only the title as well as picture of this file may have been remodelled due to the Company Specification workers the remainder of the information is auto-generated coming from a syndicated feed.) Initial Released: Oct 07 2024|5:52 PM IST.